VIATRIS INC. Assets, Fair Value Disclosure
VIATRIS INC. (VTRS) had Assets, Fair Value Disclosure of $284.70 million as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2022-02-28
- 2021-12-31: Assets, Fair Value Disclosure $284.70M.
- 2020-12-31: Assets, Fair Value Disclosure $204.40M.
- 2019-12-31: Assets, Fair Value Disclosure $109.80M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $284.70M 10-K · filed 2022-02-28 |
| 2020-12-31 | $204.40M 10-K · filed 2022-02-28 |
| 2019-12-31 | $109.80M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |